Intelligence Platform
Patents
Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted patentUS 7253147
Modified serum albumin with reduced affinity for nickel and copper
granted patentUS 7247708
Modified vitamin K-dependent polypeptides
granted patentUS 7223388
Modified reoviral therapy
granted patentUS 7220837
Modified vitamin K-dependent polypeptides
granted patentUS 7150869
Modified cytokines for use in cancer therapy
granted patentUS 7119066
Modified ciliary neurotrophic factor (CNTF)
granted patentUS 7109303
Modified cytokines for use in cancer therapy
granted patentUS 7074410
Modified HCV peptide vaccines
granted patentUS 7070959
Modified chimeric polypeptides with improved pharmacokinetic properties
granted patentUS 7067122
Modified live Edwardsiella tarda vaccine for aquatic animals
granted patentUS 7049116
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
expired patentUS 7041503
Modified myelin basic protein molecules
expired patentUS 7029899
Selective toxicity of amino-terminal modified rnase a superfamily polypeptides
expired patentUS 6991793
Method of protecting fish against columnaris disease with modified live Flavobacterium col
expired patentUS 6890518
Compositions of chemically modified insulin
expired patentUS 6884788
Thiol-modified hyaluronan
expired patentUS 6881412
Modified live Flavobacterium columnare against columnaris disease in fish
expired patentUS 6867289
Thio-modified aptamer synthetic methods and compositions
expired patentUS 6838076
Pulmonary administration of chemically modified insulin
expired patentUS 6787636
Modified serum albumin with reduced affinity for nickel and copper
expired patentUS 6762286
Modified vitamin K-dependent polypeptides
expired patentUS 6747003
Modified vitamin K-dependent polypeptides
expired patentUS 6692910
Inhibition of a target messenger RNA with a modified U1 small nuclear RNA
expired